NCT06973889View on ClinicalTrials.gov

Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

January 21, 2025

Conditions
HELICOBACTER PYLORI INFECTIONSGastrointestinal Disease
Interventions
BIOLOGICAL

Helicobacter pylori eradication therapy

12 grams of egg yolk powder containing about 2 grams of antibody twice a day for 2 weeks along with usual antibiotic treatment including OAC or omeprazole (40 mg/day), clarithromycin (1000 mg/day) and amoxicillin (2000 mg/day).

Trial Locations (2)

9177945418

Mashhad University of Medical Sciences, Mashhad

9177948564

Mashhad university of medical sciences, Mashhad

All Listed Sponsors
lead

Mashhad University of Medical Sciences

OTHER

NCT06973889 - Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients | Biotech Hunter | Biotech Hunter